Avalo Therapuetics (AVTX) Misses Q1 EPS by 125c
Tweet
Share
E-mailGet Alerts AVTX Hot Sheet
Join SI Premium – FREE
Avalo Therapuetics (NASDAQ: AVTX) reported Q1 EPS of ($1.25).
For earnings history and earnings-related data on Avalo Therapuetics (AVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- Northrop Grumman wins two U.S. defense contracts worth $38.7m
- Citrini Research acquired by Semianalysis
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
